High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China - Concepedia

Concepedia

Publication | Closed Access

High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China

11

Citations

23

References

2018

Year

Hui-Hua Jia, Kaiwen Li, Qin-Yan Chen, Xueyan Wang, Tim J. Harrison, Shujia Liang, Qingli Yang, Chao Wang, Liping Hu, Chuang-Chuang Ren,

Abstract

Treating HIV in HIV/HBV co-infection with antiretroviral agents may result in a very high prevalence of HBV 3TC-resistant mutations. TDF could not completely suppress HBV replication.

References

	Year	Citations

Page 1